Nautilus Biotechnology In... (NAUT)
Nautilus Biotechnology Statistics
Share Statistics
Nautilus Biotechnology has 126.15M shares outstanding. The number of shares has increased by 0.7% in one year.
| Shares Outstanding | 126.15M |
| Shares Change (YoY) | 0.7% |
| Shares Change (QoQ) | 0.47% |
| Owned by Institutions (%) | 50.9% |
| Shares Floating | 57.93M |
| Failed to Deliver (FTD) Shares | 53 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 872.9K, so 0.7% of the outstanding shares have been sold short.
| Short Interest | 872.9K |
| Short % of Shares Out | 0.7% |
| Short % of Float | 1.52% |
| Short Ratio (days to cover) | 5.1 |
Valuation Ratios
The PE ratio is -2.98 and the forward PE ratio is -2.42. Nautilus Biotechnology's PEG ratio is -0.3.
| PE Ratio | -2.98 |
| Forward PE | -2.42 |
| PS Ratio | 0 |
| Forward PS | 1.7 |
| PB Ratio | 1.01 |
| P/FCF Ratio | -3.44 |
| PEG Ratio | -0.3 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Nautilus Biotechnology.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.4, with a Debt / Equity ratio of 0.15.
| Current Ratio | 17.4 |
| Quick Ratio | 17.4 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | - |
| Debt / FCF | -0.5 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-456.65K |
| Employee Count | 155 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -70.78M |
| Effective Tax Rate | 100% |
Stock Price Statistics
The stock price has increased by -68.59% in the last 52 weeks. The beta is 1.07, so Nautilus Biotechnology's price volatility has been higher than the market average.
| Beta | 1.07 |
| 52-Week Price Change | -68.59% |
| 50-Day Moving Average | 1.38 |
| 200-Day Moving Average | 2.17 |
| Relative Strength Index (RSI) | 32.73 |
| Average Volume (20 Days) | 129.45K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | 0 |
| Net Income | -70.78M |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.56 |
Balance Sheet
The company has 27.65M in cash and 30.48M in debt, giving a net cash position of -2.83M.
| Cash & Cash Equivalents | 27.65M |
| Total Debt | 30.48M |
| Net Cash | -2.83M |
| Retained Earnings | -273.02M |
| Total Assets | 242.74M |
| Working Capital | 125.19M |
Cash Flow
In the last 12 months, operating cash flow was -59.15M and capital expenditures -2.12M, giving a free cash flow of -61.27M.
| Operating Cash Flow | -59.15M |
| Capital Expenditures | -2.12M |
| Free Cash Flow | -61.27M |
| FCF Per Share | -0.49 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NAUT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for NAUT is $3, which is 244.8% higher than the current price. The consensus rating is "Hold".
| Price Target | $3 |
| Price Target Difference | 244.8% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Scores
| Altman Z-Score | -0.19 |
| Piotroski F-Score | 1 |